AKT1 and non-small cell lung carcinoma: Exosomal miR-425-3p in cisplatin-resistant non-small cell lung cancer (NSCLC) promotes autophagy activation by targeting the AKT1/mTOR pathway, leading to cisplatin resistance in sensitive cells [134].